Hyperbaric oxygen therapy as an immunosensitizing strategy in advanced gastric hepatoid adenocarcinoma: a case report
This case suggests that adding HBOT may enhance the efficacy of immunotherapy and overcome resistance to ICIs in advanced HAS. These promising findings warrant further investigation through prospective clinical studies to confirm this observation.
Authors
- Menghui Xu
- Ming Liu (ORCID: https://orcid.org/0000-0002-4693-0073)
- Jing Wei (ORCID: https://orcid.org/0000-0002-8803-7056)
- Pengfei Zhang (ORCID: https://orcid.org/0000-0002-7090-0325)
- Wenke Li (ORCID: https://orcid.org/0000-0002-2172-8709)
- Lin Zhu (ORCID: https://orcid.org/0000-0002-4546-2896)
- Mo Cheng (ORCID: https://orcid.org/0009-0004-8814-4339)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Sichuan Cancer Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-06-27
- DOI
- https://doi.org/10.3389/fimmu.2025.1625273
- Citations
- 1
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.94